stars 1 stars 2 stars 3

Cannablis is, a company established to provide high end standardised medical marijuana products. The products, both smoking and non-smoking, are THC and CBD based. The company began marketing oils and cookies, and has since expanded its line to creams, suppositories and capsules. These products are manufactured in different strengths to meet the needs of the patients, their medical condition and their age. The head of the medical consultancy department is professor Reuven Or, Director of the department of bone and marrow transplantation and cancer immunotherapy and the immunobiology research center at Hadassah Ein Kerem hospital in Jerusalem. In addition, Cannabliss works in cooperation with doctors in several doctors across Israel. Over the past five years, Cannabliss has been operating a distribution and instruction centre at Hadassah Ein Kerem hospital in Jerusalem. We also provide a national home delivery service to patients. Cannabliss is looking to expand its activities worldwide and is looking for collaborations in the field of cannabis.

Cannabliss Questions

The Cannabliss annual revenue was $9.6 million in 2026.

McKenna Sawicki is the Chief Administrative Officer of Cannabliss.

4 people are employed at Cannabliss.

Cannabliss is based in Jerusalem, Jerusalem.

The NAICS codes for Cannabliss are [325, 32].

The SIC codes for Cannabliss are [283, 28].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users